Deniz Tschammler specializes on complex legal, commercial and strategic projects in the health and life sciences sector, including with respect to transactions and collaborations, disputes in and out of court, market access and reimbursement pathways, competition strategies, marketing and promotion concepts, as well as sector-specific anti-bribery, data protection and compliance matters. He also advises in the areas of health politics, foreign trade and foreign investment control.

Deniz has deep regulatory and economic expertise and an excellent understanding of pharmaceutical and medical issues. He has been recognized as a Rising Star in the German and European health market by The Legal 500, LMG and JUVE. Deniz is the author of numerous articles in the field of health law.

• Advising a research-based pharmaceutical company in negotiations with the German Federal Ministry of Health concerning the procurement of COVID-19 therapeutics
• Advising a research-based pharmaceutical company in connection with a cooperation agreement regarding the EU-wide distribution of respiratory drugs
• Advised a global internet company on telemedical business models in times of the COVID-19 crisis

Show More

• LMG 2021: Recognized as European Rising Star in Life Sciences
• The Legal 500 Germany 2021: Recognized as Rising Star in Healthcare and Life Sciences
• JUVE Handbook 2020/2021: Recognized as Rising Star in Healthcare and Life Sciences (under 40)
• Rising Star, Tax – Euromoney Expert Guide 2021

Education
University of St. Gallen, Executive MBA, 2021
King’s College London, LLM, 2013
Higher Regional Court of Wiesbaden, Second State Examination, 2012
Philipps University of Marburg, PhD, 2011
Goethe University of Frankfurt, First State Examination, 2008
Universities of Frankfurt and Lyon, Diploma in French Law, 2007

Admissions
Germany

Languages
English
German